1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ß-HSD1 inhibitors for the treatment of diabetes

Authors:
  • CEChristian K. Engel
    Christian K. Engel
  • GFGéraldine Farjot
    Géraldine Farjot
  • SGStefan Güssregen
    Stefan Güssregen
  • THTorsten Haack
    Torsten Haack
  • GTGeorg Tschank
    Georg Tschank
  • KRKurt Ritter
    Kurt Ritter

Abstract
No abstract available

This publication has 36 references indexed in Scilit: